Cheryl Allen, BS Pharm, MBA, founding partner, highlights the coming year's focus on navigating an evolving regulatory ...

At a time when investors are questioning the sustainability of pharmaceutical business models, reliable execution has become ...

Modern PBMs, or PBM-like functions, should operate with full line-of-sight to net price and patient outcomes. Full ...

Although he typically revises his macro framework only once every decade or more, Roth explained that the current environment ...

One of which revolved around “Optimizing GTN Strategy—Balancing Channel Economics and Market Access,” led by Lannett ...